vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Elme Communities (ELME). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $62.1M, roughly 1.0× Elme Communities). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -198.9%, a 128.0% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 1.7%). Elme Communities produced more free cash flow last quarter ($7.2M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 2.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
CTKB vs ELME — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $62.1M |
| Net Profit | $-44.1M | $-123.5M |
| Gross Margin | 52.9% | 61.1% |
| Operating Margin | -9.0% | -183.3% |
| Net Margin | -70.9% | -198.9% |
| Revenue YoY | 8.1% | 1.7% |
| Net Profit YoY | -557.1% | -4058.7% |
| EPS (diluted) | — | $-1.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | — | ||
| Q3 25 | $52.3M | $62.1M | ||
| Q2 25 | $45.6M | $62.1M | ||
| Q1 25 | $41.5M | $61.5M | ||
| Q4 24 | $57.5M | $61.3M | ||
| Q3 24 | $51.5M | $61.1M | ||
| Q2 24 | $46.6M | $60.1M | ||
| Q1 24 | $44.9M | $59.5M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $-123.5M | ||
| Q2 25 | $-5.6M | $-3.6M | ||
| Q1 25 | $-11.4M | $-4.7M | ||
| Q4 24 | $9.6M | $-3.0M | ||
| Q3 24 | $941.0K | $-3.0M | ||
| Q2 24 | $-10.4M | $-3.5M | ||
| Q1 24 | $-6.2M | $-3.6M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | 61.1% | ||
| Q2 25 | 52.3% | 63.5% | ||
| Q1 25 | 48.6% | 64.2% | ||
| Q4 24 | 58.5% | 62.9% | ||
| Q3 24 | 56.3% | 63.5% | ||
| Q2 24 | 54.6% | 63.4% | ||
| Q1 24 | 51.3% | 63.5% |
| Q4 25 | -9.0% | — | ||
| Q3 25 | -17.6% | -183.3% | ||
| Q2 25 | -23.3% | 9.6% | ||
| Q1 25 | -36.1% | 7.8% | ||
| Q4 24 | 5.2% | 10.4% | ||
| Q3 24 | -8.2% | 11.0% | ||
| Q2 24 | -18.3% | 9.8% | ||
| Q1 24 | -23.9% | 7.5% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | -198.9% | ||
| Q2 25 | -12.2% | -5.7% | ||
| Q1 25 | -27.5% | -7.6% | ||
| Q4 24 | 16.8% | -4.9% | ||
| Q3 24 | 1.8% | -4.9% | ||
| Q2 24 | -22.4% | -5.8% | ||
| Q1 24 | -13.8% | -6.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.40 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $7.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $908.9M |
| Total Assets | $461.5M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | $7.1M | ||
| Q2 25 | $75.5M | $4.8M | ||
| Q1 25 | $95.3M | $6.4M | ||
| Q4 24 | $98.7M | $6.1M | ||
| Q3 24 | $162.3M | $4.8M | ||
| Q2 24 | $177.9M | $5.6M | ||
| Q1 24 | $168.8M | $4.2M |
| Q4 25 | $341.7M | — | ||
| Q3 25 | $378.6M | $908.9M | ||
| Q2 25 | $377.6M | $1.0B | ||
| Q1 25 | $379.6M | $1.1B | ||
| Q4 24 | $395.7M | $1.1B | ||
| Q3 24 | $385.5M | $1.1B | ||
| Q2 24 | $389.1M | $1.1B | ||
| Q1 24 | $392.6M | $1.1B |
| Q4 25 | $461.5M | — | ||
| Q3 25 | $494.9M | $1.7B | ||
| Q2 25 | $493.3M | $1.8B | ||
| Q1 25 | $482.6M | $1.8B | ||
| Q4 24 | $499.5M | $1.8B | ||
| Q3 24 | $491.2M | $1.9B | ||
| Q2 24 | $483.7M | $1.9B | ||
| Q1 24 | $492.1M | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $15.9M |
| Free Cash FlowOCF − Capex | $-1.8M | $7.2M |
| FCF MarginFCF / Revenue | -2.9% | 11.6% |
| Capex IntensityCapex / Revenue | 1.6% | 14.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $86.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | — | ||
| Q3 25 | $-3.9M | $15.9M | ||
| Q2 25 | $108.0K | $29.8M | ||
| Q1 25 | $-125.0K | $16.2M | ||
| Q4 24 | $2.0M | $95.2M | ||
| Q3 24 | $13.2M | $20.7M | ||
| Q2 24 | $6.2M | $28.9M | ||
| Q1 24 | $4.0M | $21.2M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | $7.2M | ||
| Q2 25 | $-1.5M | $21.1M | ||
| Q1 25 | $-974.0K | $10.5M | ||
| Q4 24 | $1.1M | $47.9M | ||
| Q3 24 | $12.2M | $8.8M | ||
| Q2 24 | $5.2M | $21.0M | ||
| Q1 24 | $3.4M | $7.6M |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | 11.6% | ||
| Q2 25 | -3.2% | 34.1% | ||
| Q1 25 | -2.3% | 17.1% | ||
| Q4 24 | 1.9% | 78.1% | ||
| Q3 24 | 23.7% | 14.4% | ||
| Q2 24 | 11.0% | 34.9% | ||
| Q1 24 | 7.6% | 12.8% |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | 14.0% | ||
| Q2 25 | 3.5% | 14.0% | ||
| Q1 25 | 2.0% | 9.2% | ||
| Q4 24 | 1.6% | 77.4% | ||
| Q3 24 | 2.0% | 19.4% | ||
| Q2 24 | 2.3% | 13.1% | ||
| Q1 24 | 1.3% | 22.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
